Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

被引:193
作者
Joniau, Steven [1 ]
Van den Bergh, Laura [2 ]
Lerut, Evelyne [3 ]
Deroose, Christophe M. [4 ]
Haustermans, Karin [2 ]
Oyen, Raymond [5 ]
Budiharto, Tom [2 ]
Ameye, Filip [1 ]
Bogaerts, Kris [6 ]
Van Poppel, Hein [1 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Urol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Dept Radiat Oncol, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Histopathol, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Nucl Med, B-3000 Louvain, Belgium
[5] Katholieke Univ Leuven Hosp, Dept Radiol, B-3000 Louvain, Belgium
[6] Catholic Univ Louvain, B-3000 Louvain, Belgium
关键词
Lymphadenectomy; Lymph node dissection template; Lymph node staging; Prostate cancer; RADICAL RETROPUBIC PROSTATECTOMY; LYMPHADENECTOMY; DISSECTION;
D O I
10.1016/j.eururo.2012.06.057
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Opinions about the optimal lymph node dissection (LND) template in prostate cancer differ. Drainage and dissemination patterns are not necessarily identical. Objective: To present a precise overview of the lymphatic drainage pattern and to correlate those findings with dissemination patterns. We also investigated the relationship between the number of positive lymph nodes (LN+) and resected lymph nodes (LNs) per region. Design, setting, and participants: Seventy-four patients with localized prostate adenocarcinoma were prospectively enrolled. Patients did not show suspect LNs on computed tomography scan and had an LN involvement risk of >= 10% but <= 35% (Partin tables) or a cT3 tumor. Intervention: After intraprostatic technetium-99m nanocolloid injection, patients underwent planar scintigraphy and single-photon emission computed tomography imaging. Then surgery was performed, starting with a sentinel node (SN) procedure and a superextended lymphadenectomy followed by radical prostatectomy. Outcome measurements and statistical analysis: Distribution of scintigraphically detected SNs and removed SNs per region were registered. The number of LN+, as well as the percentage LN+ of the total number of removed LNs per region, was demonstrated in combining data of all patients. The impact of the extent of LND on N-staging and on the number of LN+ removed was calculated. Results and limitations: A total of 470 SNs were scintigraphically detected (median: 6; interquartile range [IQR]: 3-9), of which 371 SNs were removed (median: 4; IQR: 2.25-6). In total, 91 LN+(median: 2; IQR: 1-3) were found in 34 of 74 patients. The predominant site for LN+ was the internal iliac region. An extended LND(eLND) would have correctly staged 32 of 34 patients but would have adequately removed all LN+ in only 26 of 34 patients. When adding the presacral region, these numbers increased to 33 of 34 and 30 of 34 patients, respectively. Conclusions: Standard eLND would have correctly staged the majority of LN+ patients, but 13% of the LN+ would have been missed. Adding the presacral LNs to the template should be considered to obtain a minimal template with maximal gain. Note: This manuscript was invited based on the 2011 European Association of Urology meeting in Vienna. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:450 / 458
页数:9
相关论文
共 50 条
  • [21] See the unseen: Mesorectal lymph node metastases in prostate cancer
    Hijazi, Sameh
    Meller, Birgit
    Leitsmann, Conrad
    Strauss, Arne
    Ritter, Christian
    Lotz, Joachim
    Meller, Johannis
    Trojan, Lutz
    Sahlmann, Carsten-Oliver
    [J]. PROSTATE, 2016, 76 (08) : 776 - 780
  • [22] Assessing the most accurate formula to predict the risk of lymph node metastases from prostate cancer in contemporary patients treated with radical prostatectomy and extended pelvic lymph node dissection
    Abdollah, Firas
    Cozzarini, Cesare
    Sun, Maxine
    Suardi, Nazareno
    Gallina, Andrea
    Passoni, Niccolo Maria
    Bianchi, Marco
    Tutolo, Manuela
    Fossati, Nicola
    Nini, Alessandro
    Dell'Oglio, Paolo
    Salonia, Andrea
    Karakiewicz, Pierre
    Montorsi, Francesco
    Briganti, Alberto
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 109 (02) : 211 - 216
  • [23] Prevalence and size of pelvic sentinel lymph node metastases in endometrial cancer
    Bollino, Michele
    Geppert, Barbara
    Lonnerfors, Celine
    Masback, Anna
    Kasselaki, Ioanna
    Persson, Jan
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 209
  • [24] PROSTATE CANCER How to manage prostate cancer with lymph node metastases?
    Janetschek, Guenter
    Hruby, Stephan
    [J]. NATURE REVIEWS UROLOGY, 2014, 11 (03) : 137 - 138
  • [25] Pelvic Lymph Node Dissection for Prostate Cancer: Frequency and Distribution of Nodal Metastases in a Contemporary Radical Prostatectomy Series
    Godoy, Guilherme
    von Bodman, Christian
    Chade, Daher C.
    Dillioglugil, Ozdal
    Eastham, James A.
    Fine, Samson W.
    Scardino, Peter T.
    Laudone, Vincent P.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (06) : 2082 - 2086
  • [26] Deep Inguinal Lymph Node Metastases Can Predict Pelvic Lymph Node Metastases and Prognosis in Penile Squamous Cell Carcinoma
    Yang, Zhenyu
    Tan, Xingliang
    Wang, Yanjun
    Zou, Yuantao
    Chen, Dong
    Wu, Zhiming
    Liu, Zhuowei
    Li, Yonghong
    Qin, Zike
    Han, Hui
    Zhou, Fangjian
    Yao, Kai
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Pelvic lymph node dissection in prostate cancer staging: evaluation of morbidity and oncological outcomes
    Van Huele, Andries
    Poelaert, Filip
    Fonteyne, Valerie
    Decaestecker, Karel
    Ost, Piet
    Lumen, Nicolaas
    [J]. ACTA CHIRURGICA BELGICA, 2019, 119 (02) : 103 - 109
  • [28] Indications, Extent, and Benefits of Pelvic Lymph Node Dissection for Patients with Bladder and Prostate Cancer
    Thurairaja, Ramesh
    Studer, Urs E.
    Burkhard, Fiona C.
    [J]. ONCOLOGIST, 2009, 14 (01) : 40 - 51
  • [29] Clinical significance of pelvic lymph node status in prostate cancer: review of 1690 cases
    Maccio, Livia
    Barresi, Valeria
    Domati, Federica
    Martorana, Eugenio
    Cesinaro, Anna Maria
    Migaldi, Mario
    Iachetta, Francesco
    Ieni, Antonio
    Bonetti, Luca Reggiani
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (03) : 399 - 404
  • [30] Complications of pelvic lymph node dissection for prostate cancer
    Keegan K.A.
    Cookson M.S.
    [J]. Current Urology Reports, 2011, 12 (3) : 203 - 208